3:00
Change.org is on track to have more compassionate use petitions this year than ever, with seven new petitions since Jan. 1. Last year, there were 20 compassionate use petitions on the site compared with just three in 2009. In 2013, each of these petitions got about 47,000 signatures on average compared to just 296 signatures per petition on average in 2009.
Compassionate use petitions make up only a tiny portion of Change.org’s health petitions, which numbered 11,138 in the site's history, garnering nearly 21 million signatures and 325 victories, Newman said.
Though the number of drug access petitions on Change.org has gone up over the last five years, the number of compassionate use applications submitted to the FDA for approval has fluctuated and appears to be trending downward. (To submit an application to the FDA, a doctor must have the drug company on board to provide the drug.)
In the fiscal year ending in September 2011, the FDA received 1,200 applications for compassionate use programs for investigational new drugs, or INDs, and approved 1,199 of them, according to the agency. But in the fiscal year ending in September 2013, the most recent one available, it received applications for only 977 programs and approved 974 of them.
Compassionate use can occasionally hurt a company’s ability to bring a drug to market quickly, slowing the process by diverting the drug itself, resources and time, experts said. If a patient dies while taking the experimental drug under compassionate use –- even of unrelated causes -- it may slow down the approval process for a drug because the company has to prove that the drug didn’t contribute to the patient’s death.
“Compassionate use often fails,” NYU's Caplan noted. “It is not due to the drug –- just that the drug frequently does not cure.”
The alternative for these patients is often death, so they fight for access to the experimental drugs because they want to know they did everything they could.
\"I have been given a zero chance of survival past the next few months without this drug,\" Change.org petitioner Nick Auden told ABCNews.com in an email last October.
Auden’s campaign was one of the most successful compassionate use campaigns on Change.org, gathering more than half a million signatures to convince Merck or Bristol-Myers Squibb to give him access to their breakthrough cancer drug. His wife came up with the idea to post a video of Auden playing with their young children to drum up support, and they named it the “Save Locky’s Dad” campaign for their oldest son, Locky, 7.
\"I want my dad to get the PD-1 drug because then I can do the things I like to do with him all the time,\" Locky says in the video, flashing a smile that's missing two front teeth.
Merck eventually expanded access to its drug to other melanoma patients this month, but it was too late for Auden.
He died at home in November.
","canonicalUrl":"https://abcnews.com/Health/social-media-push-experimental-drugs-rise/story?id=23143393","legacySlug":"/wellness/story/social-media-push-experimental-drugs-rise-23143393","noIndexNoFollow":false},"publishTime":"15:52","publishDate":"04-02-2014","updatedTime":"14:00","updatedDate":"05-15-2014","socialImage":{"alt":"Josh Hardy, 7, has beat cancer four times, but a virus could kill him.","credit":"Courtesy Aimee Hardy","ratio":"16x9","url":"https://s.abcnews.com/images/Health/HT_Josh_Harding1_ml_140310_16x9_992.jpg","width":992,"height":558},"datePublished":"4/2/2014 15:52:30 GMT","video":{"live":false,"id":23143393,"headline":"AC","mediaAssetTitle":"LUPKIN_change.org_comp_use_140402","description":"Change.org on track to receive more experimental drug petitions than ever.","duration":"3:00","posterImg":{"url":"https://s.abcnews.com/images/GMA/default-img-undefined.png","width":608,"height":342},"video":{"feed":"https://service-pkgabcnews.akamaized.net/opp/hls/abcnews/i/abcnews/140327_gma_avila_0714_,800,1200,1800,2500,3200,4500,.mp4.csmil/playlist.m3u8"},"playlist":["23084803","20235958","22954543"]},"relatedItems":[{"contentType":"blogentry","date":"March 27, 2014","headline":"Dying Woman's Hope Buoyed by Campaign for Experimental Drug","section":"news","slug":"/news/blogentry/-23084803","id":23084803,"image":{"alt":"Dying Woman's Hope Buoyed by Campaign for Experimental Drug","url":"","credit":"","ratio":"1x1"}},{"contentType":"story","date":"September 13, 2013","headline":"Dying Dad Pleads for Unapproved Cancer Drug","section":"news","slug":"/news/story/dying-dad-pleads-unapproved-cancer-drug-20235958","id":20235958,"image":{"alt":"Dying Dad Pleads for Unapproved Cancer Drug","url":"https://s.abcnews.com/images/Health/HT_Nick_Auden_lpl_130912_4x3t_240.jpg","credit":"Catherine Sutherland","ratio":"1x1"}},{"contentType":"story","date":"March 18, 2014","headline":"Merck Expands Cancer Drug Access But Too Late for Denver Dad","section":"news","slug":"/news/story/merck-expands-cancer-drug-access-late-denver-dad-22954543","id":22954543,"image":{"alt":"Merck Expands Cancer Drug Access But Too Late for Denver Dad","url":"https://s.abcnews.com/images/Health/HT_Nick_Auden_lpl_130912_4x3t_240.jpg","credit":"Catherine Sutherland","ratio":"1x1"}}],"relatedContentSection":"news","schemaContent":{"name":"AC","description":"Change.org on track to receive more experimental drug petitions than ever.","duration":"3:00","uploadDate":"04-02-2014","publication":"04-02-2014","images":"https://s.abcnews.com/images/GMA/default-img-undefined.png","url":"https://service-pkgabcnews.akamaized.net/opp/hls/abcnews/i/abcnews/140327_gma_avila_0714_,800,1200,1800,2500,3200,4500,.mp4.csmil/playlist.m3u8","contentUrl":"https://service-pkgabcnews.akamaized.net/opp/hls/abcnews/i/abcnews/140327_gma_avila_0714_,800,1200,1800,2500,3200,4500,.mp4.csmil/playlist.m3u8","link":"https://www.goodmorningamerica.com/news/story/social-media-push-experimental-drugs-rise-23143393"}},"playlist":[{"id":"132283010","contentType":"story","section":"news"},{"id":"132273278","contentType":"story","section":"news"},{"id":"132231169","contentType":"story","section":"news"},{"id":"132206748","contentType":"story","section":"news"},{"id":"132200241","contentType":"story","section":"news"},{"id":"132054443","contentType":"story","section":"news"},{"id":"132054798","contentType":"story","section":"news"},{"id":"132033010","contentType":"story","section":"news"},{"id":"131912713","contentType":"story","section":"news"},{"id":"131830583","contentType":"story","section":"news"},{"id":"131834976","contentType":"story","section":"news"},{"id":"131554765","contentType":"story","section":"news"},{"id":"131554815","contentType":"story","section":"news"},{"id":"131543053","contentType":"story","section":"news"},{"id":"131432442","contentType":"story","section":"news"},{"id":"131121474","contentType":"story","section":"news"},{"id":"131247079","contentType":"story","section":"news"},{"id":"131228784","contentType":"story","section":"news"},{"id":"131178806","contentType":"story","section":"news"},{"id":"131142257","contentType":"story","section":"news"}],"kvps":{"pgtyp":"article","lang":"en","sp":"goodmorningamerica","programmatic":"true","bundleId":"com.abcnews"}},"analytics":{"accountID":"wdgnewwdgnewgmaweb","ns":"gma","pageName":"gma:news:video","pageType":"video","globalSpecVersion":"v1.08","siteDifferentiator":"gma:site","tagID":"g_page01","userABCookie":"0","section":"news","title":"AC","pubTime":"11:52","pubDate":"04-02-2014","modTime":"10:00","modDate":"05-15-2014","taxonomyTags":"none","id":23143393,"editorialOtherSubjects":"","wordCount":"none","columns":"none","authors":"","authorsUnit":"none","authorsBureau":"none","subBrand":"Good Morning America","provider":"Good Morning America","videoName":"AC","mediaAssetTitle":"LUPKIN_change.org_comp_use_140402","videoId":23143393,"mediaOnPage":"video","legacySlug":"/wellness/story/social-media-push-experimental-drugs-rise-23143393"},"taboola":{}},"request":{"headers":{},"httpVersion":"1.1","method":"GET","url":"/video/23143393","vary":{"host":"www.goodmorningamerica.com","cached":true,"path":"/video/23143393","forwarded-proto":"https","device":"desktop","userab":"0"}},"viewport":{"width":1260,"height":0},"user":{}};